As such, Adam2 expression and the associated decreased IFN signaling appears to result in a less exhausted tumor microenvironment, which is highly permissive to ex vivo expanded, adoptively transferred cytotoxic T cells or rejuvenated endogenous cytotoxic T cells. The gene discussed is ADAM2; the disease is neoplasm.